基因编辑权威指南。
菜单
首页 学习 新闻 向 Atlas 提问
探索 技术 疾病 治疗方法 临床试验 企业 科学家 基因 研究 机构
医学之外 农业 伦理 投资 世界地图
学习与工具 从这里开始 术语表 A–Z 对比技术 时间线 列表与排名 AI 智能体 ★ 已保存 API
关于 关于我们 方法论 数据来源 编辑方针 联系我们 免责声明

🧭 引导视图
遗传学新手?浏览时我们会用简单易懂的语言为您解释每个术语,就在同一页面内,帮助随时可用。

⚡ 专家观点
你已经了解生物学基础,只需内容本身——简洁明了,无额外解释。这是默认视图。

界面语言
浅色模式

临床试验 · Hereditary angioedema

The Phase 1/2 study that took lonvo-z into late-stage development

官方名称: A Study of NTLA-2002 in Adults With Hereditary Angioedema

Completed Phase I/II NCT05120830
Clinical research Being tested in people in registered clinical trials. Being in trials is not evidence that a treatment works or is safe.

本试验正在测试什么

The earlier trial of the hereditary angioedema treatment, testing whether a single infusion could reduce swelling attacks. Its results were published in a major medical journal and supported the move into the Phase 3 study that followed.

A Phase 1/2 study of NTLA-2002 in adults with hereditary angioedema, evaluating safety, pharmacodynamics and attack rate following a single dose. Results were published in the New England Journal of Medicine and supported progression to the Phase 3 HAELO study.

Sources

试验结果意味着什么,又不意味着什么 早期试验结果来自少量参与者和较短的随访周期,随着人数增加和时间延长,结论可能发生变化。正在招募、进行中甚至已完成的试验,并不代表某种疗法已被证实有效。入组标准十分严格,是否符合条件由试验机构决定,而非由网站判断。

Connected in the Atlas

Every entry on this site is linked to the others it relates to. These connections are part of the record, not a search result.